Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Carbone
Alex A Adjei

Showing results (1-10 of 372) with videos related to

Pageof 38
Sort By:
Clinical Lung Cancer|March 27, 2007
Novel small-molecule inhibitors of the vascular endothelial growth factor receptorAlex A Adjei
Clinical Lung Cancer|October 28, 2005
Sequencing bortezomib with chemotherapy and targeted agentsAlex A Adjei
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
An overview of farnesyltransferase inhibitors and their role in lung cancer therapyAlex A Adjei
Clinical Lung Cancer|January 15, 2004
Current data with pemetrexed (Alimta) in non-small-cell lung cancerAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2018
WITHDRAWN: What is a "High-Impact" Journal?Alex A Adjei
Expert Review of Anticancer Therapy|May 2, 2003
Pemetrexed (Alimta): a novel multitargeted antifolate agentAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
K-ras as a target for lung cancer therapyAlex A Adjei
Clinical Breast Cancer|June 12, 2002
Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanesAlex A Adjei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agentAlex A Adjei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Novel combinations based on epidermal growth factor receptor inhibitionAlex A Adjei
Pageof 38

Showing results (1-10 of 372) with videos related to

Sort By:
Pageof 38
Clinical Lung Cancer|March 27, 2007
Novel small-molecule inhibitors of the vascular endothelial growth factor receptorAlex A Adjei
Clinical Lung Cancer|October 28, 2005
Sequencing bortezomib with chemotherapy and targeted agentsAlex A Adjei
Lung Cancer (Amsterdam, Netherlands)|July 18, 2003
An overview of farnesyltransferase inhibitors and their role in lung cancer therapyAlex A Adjei
Clinical Lung Cancer|January 15, 2004
Current data with pemetrexed (Alimta) in non-small-cell lung cancerAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 31, 2018
WITHDRAWN: What is a "High-Impact" Journal?Alex A Adjei
Expert Review of Anticancer Therapy|May 2, 2003
Pemetrexed (Alimta): a novel multitargeted antifolate agentAlex A Adjei
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 27, 2008
K-ras as a target for lung cancer therapyAlex A Adjei
Clinical Breast Cancer|June 12, 2002
Pemetrexed (Alimta) and gemcitabine in breast cancer patients previously treated with anthracyclines and taxanesAlex A Adjei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2004
Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agentAlex A Adjei
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 22, 2006
Novel combinations based on epidermal growth factor receptor inhibitionAlex A Adjei
Pageof 38